Please use this identifier to cite or link to this item:
Type
ArticleCopyright
Open access
Collections
- ENSP - Artigos de Periódicos [2412]
- IOC - Artigos de Periódicos [12982]
Metadata
Show full item record
WHO GLOBAL RESEARCH PRIORITIES FOR ANTIMICROBIAL RESISTANCE IN HUMAN HEALTH
Anna Cristina Calçada Carvalho – Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Inovações em Terapias, Ensino e Bioprodutos. Rio de Janeiro, RJ, Brasil. Documento produzido em parceria ou por autor vinculado à Fiocruz, mas não consta a informação no documento.
Paulo Redner – Fundação Oswaldo Cruz. Escola Nacional de Saúde Pública Sergio Arouca. Centro de Referência Professor Hélio Fraga. Rio de Janeiro, RJ, Brasil. Documento produzido em parceria ou por autor vinculado à Fiocruz, mas não consta a informação no documento.
WHO Research Agenda for AMR in Human Health Collaborators: David Aanensen (University of Oxford, United Kingdom), Alexandre Alanio (Institut Pasteur, Université Paris Cité, National Reference Center for Invasive Mycoses and Antifungals, Translational Mycology research group, Mycology Department, Paris, France; Laboratoire de parasitologie-mycologie, AP-HP, Hôpital Saint-Louis, Paris, France), Ana Alastruey-Izquierdo (Instituto de Salud Carlos III, Spain), Tinsae Alemayehu (St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia and American medical center, Addis Ababa, Ethiopia), Majdi Al-Hasan (University of South Carolina School of Medicine; Prisma Health-Midlands, Columbia, South Carolina, United States of America), Karel Allegaert (KU Leuven, Belgium), Amal Saif Al-Maani (Ministry of Health, Oman), Jameela Al-Salman (Salmaniya Medical Complex, Bahrain), Abeer Nizar Alshukairi (Alfaisal University in Riyadh, Saudi Arabia; Previously King Faisal Specialist Hospital and Research Center in Jeddah, Saudi Arabia), Afreenish Amir (National Institute of Health, Pakistan), Tanya Applegate (Kirby Institute, UNSW Sydney, Australia), George F Araj (American University of Beirut - Medical Center, Lebanon), Marlen Arce Villalobos (Ministerio de Salud, Costa Rica), Christine Årdal (Norwegian Institute of Public Health, Norway), Diane Ashiru-Oredope (UK Health Security Agency, United Kingdom), Elizabeth A Ashley (Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU), Mahosot Hospital, Vientiane, Lao PDR; Centre for Tropical Medicine & Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK), François-Xavier Babin (Fondation Mérieux, France), Laura H Bachmann (Centers for Disease Control and Prevention, United States of America), Till Bachmann (Centre for Inflammation Research, Institute for Regeneration and Repair, The University of Edinburgh, Edinburgh), Kate Susan Baker (Department of Genetics, University of Cambridge, Downing Place, Cambridge, United Kingdom), Manica Balasegaram (Global Antibiotic R&D Partnership (GARDP)), Colleen Bamford (Pathcare, South Africa), Fernando Baquero (Ramón y Cajal Institute for Health Research, Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Spain), Laura Isabel Barcelona (Ministerio de Salud de la Nación, Argentina), Quique Bassat (Barcelona Institute for Global Health (ISGlobal), Spain), Matteo Bassetti (University of Genoa, Italy), Sulagna Basu (ICMR-National Institute of Cholera and Enteric Diseases, Kolkata, India), Justin Beardsley (University of Sydney, Australia), Grey Benoit Vásquez (Dirección de Epidemiología, Ministerio de Salud Pública y Asistencia Social, Dominican Republic), James A Berkley (KEMRI/Wellcome Trust Research Programme, Kilifi, Kenya; Centre for Tropical Medicine & Global Health, University of Oxford, UK), Anuj K Bhatnagar (Rajan Babu Institute for Pulmonary Medicine and Tuberculosis, India), Julia Bielicki (St George's University of London, United Kingdom; University of Basel Children's Hospital, Switzerland), Julie Bines (The University of Melbourne; Murdoch Children's Research Institute; Department of Gastroenterology and Clinical Nutrition, The Royal Children's Hospital), Felix Bongomin (Gulu University, Uganda), Robert A Bonomo (Cleveland VA Medical Center, Case Western Reserve University, United States of America), John S Bradley (University of California, San Diego, School of Medicine), Catriona Bradshaw (Monash University, Australia), Ana Brett (Clínica Universitária de Pediatria, Faculdade de Medicina, Universidade de Coimbra, Portugal), Adrian Brink (University of Cape Town, South Africa), Colin Brown (UK Health Security Agency, United Kingdom), Jeremy Brown (University College London, United Kingdom), Kirsty Buising (Victorian Infectious Diseases Unit, Royal Melbourne Hospital, Australia; Department of Infectious Diseases, University of Melbourne, Australia), Carolee Carson (Public Health Agency of Canada, Canada), Anna Cristina Calçada Carvalho (Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Inovações em Terapias, Ensino e Bioprodutos. Rio de Janeiro, RJ, Brasil), Elio Castagnola (IRCCS Istituto Giannina Gaslini, Italy), Marco Cavaleri (European Medicines Agency, Netherlands), Michele Cecchini (Organisation for Economic Co-operation and Development (OECD), France), Chishala Chabala (University of Zambia, Zambia), Richard E Chaisson (Johns Hopkins University School of Medicine; Johns Hopkins Center for Tuberculosis Research; Johns Hopkins Center for AIDS Research), Arunaloke Chakrabarti (Doodhadhari Burfani Hospital and Research Institute, Haridwar, India), Clare Chandler (London School of Hygiene and Tropical Medicine, United Kingdom), Sujith John Chandy (Department of Pharmacology & Clinical Pharmacology, Christian Medical College, Vellore, India), Esmita Charani (Imperial College London, United Kingdom), Lisa Chen (UCSF Curry International Tuberculosis Center, United States of America), Francesca Chiara (Center for Infectious Disease Research and Policy, United States of America), Anuradha Chowdhary (Medical Mycology Unit, Department of Microbiology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi; National Reference Laboratory For Antimicrobial Resistance in Fungal Pathogens, Medical Mycology Unit, Department of Microbiology, Patel Chest Institute, University of Delhi, Delhi, India), Arlene Chua (Médecins Sans Frontières, Switzerland), Pem Chuki (Jigme Dorji Wangchuck National Referral Hospital, Bhutan), Doo Ryeon Chun (Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea), Gavin Churchyard (The Aurum Institute, Parktown, South Africa; Department of Medicine, Vanderbilt University, Nashville, TN, US), Daniela Cirillo (San Raffaele Scientific Institute, Italy), Lauren Clack (University of Zurich, Institute for Implementation Science in Health Care, Zurich, Switzerland), Susan E Coffin (Children's Hospital of Philadelphia /University of Pennsylvania School of Medicine, United States of America), Jennifer Cohn (Global Antibiotic R&D Partnership (GARDP)), Michelle Cole (STI Reference Laboratory, UKHSA, London, UK), John Conly (University of Calgary and Alberta Health Services, Canada), Ben Cooper (University of Oxford, United Kingdom), Alejandra Corso (Servicio Antimicrobianos - INEI ANLIS Dr Carlos G. Malbrán, Argentina), Sara E Cosgrove (Johns Hopkins University School of Medicine, United States of America), Helen Cox (Institute of Infectious Diseases and Molecular Medicine, Division of Medical Microbiology, University of Cape Town), Charles L Daley (National Jewish Center, United States of America), Saffiatou Darboe (MRC Unit The Gambia at the LSHTM), Tom Darton (University of Sheffield, United Kingdom), Gerry Davies (University of Liverpool, United Kingdom), Viviana de Egea (Ministry of Health, Paraguay), Amela Dedeić-Ljubović (Clinical Center of the University Sarajevo, Bosnia and Herzegovina), Miranda Deeves (World Health Organization, Geneva, Switzerland), Claudia Denkinger (Division of Infectious Disease and Tropical Medicine, German Center for Infection Research (DZIF) partner site, University Hospital Heidelberg, Germany), Jo-Anne R Dillon (University of Saskatchewan, Canada), Angela Dramowski (Stellenbosch University, South Africa), Brian Eley (Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa), Susanna Maria Roberta Esposito (University of Parma, Italy), Sabiha Y Essack (Antimicrobial Research Unit, School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa), Helmia Farida (Universitas Diponegoro, Indonesia), Joveria Farooqi (Aga Khan University, Karachi, Pakistan), Nicholas Feasey (School of Medicine, University of St Andrews, St Andrews, UK and Liverpool School of Tropical Medicine, Liverpool, UK), Cecilia Ferreyra (FIND, Switzerland), Helen Fifer (UK Health Security Agency, United Kingdom), Heather Finlayson (FIND, Switzerland), Mike Frick (Treatment Action Group, United States of America), Ana Cristina Gales (Universidade Federal de São Paulo, Brazil), Luisa Galli (Department of Health Science, University of Florence and Infectious Disease Unit, Meyer Children's Hospital, IRCCS, Florence, Italy), Sumanth Gandra (Washington University School of Medicine in St. Louis, United States of America), Jeffrey S Gerber (Children's Hospital of Philadelphia, United States of America), Christian Giske (Karolinska Institute, Sweden), Bruce Gordon (World Health Organization, Geneva, Switzerland), Nelesh Govender (National Institute for Communicable Diseases, South Africa), Nathalie Guessennd (Institut Pasteur de Côte d'Ivoire, Ivory Coast), Ibrehima Guindo (National Institute of Public Health, Bamako-Mali, Mali), Elmira Gurbanova (Tartu University Clinic, Estonia), Amanda Gwee (Department of General Medicine, Royal Children's Hospital, Antimicrobials Group, Murdoch Children's Research Institute, Department of Paediatrics, The University of Melbourne), Ferry Hagen (Westerdijk Fungal Biodiversity Institute (WI-KNAW), Netherlands), Stephan Harbarth (University Hospital Geneva (HUG), Switzerland), John Haze (Ministry of Health, St Vincent & the Grenadines), Jutta Heim (Helmholtz Centre for Infection Research, Switzerland), Rene Hendriksen (Technical University of Denmark, Denmark), Robert Simon Heyderman (University College London (UCL), United Kingdom), Kathryn Elizabeth Holt (London School of Hygiene and Tropical Medicine, United Kingdom), Martin Hönigl (Medical University of Graz, Austria), Edward W Hook (University of Alabama at Birmingham, United States of America), William Hope (University of Liverpool, United Kingdom), Heidi Hopkins (London School of Hygiene and Tropical Medicine, United Kingdom), Gwenda Hughes (London School of Hygiene and Tropical Medicine, United Kingdom), Ghada Ismail (Supreme Council for University Hospitals, Egypt), Mohammad Iqbal Issack (Central Health Laboratory, Ministry of Health and Wellness, Mauritius), Jan Jacobs (Institute of Tropical Medicine, Antwerp, Belgium), Dušan Jasovský (Médecins Sans Frontières Access Campaign, Switzerland), Fyeza Jehan (The Aga Khan University, Pakistan), Antonieta Jimenez Pearson (National Reference Center of Bacteriology - INCIENSA, Costa Rica), Makoto Jones (University of Utah, United States of America), Mohan P Joshi (Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program, Management Sciences for Health, United States of America), Arti Kapil (North DMC Medical College and Hindu Rao Hospital, India), Samuel Kariuki (Director Eastern Africa, Drugs for Neglected Diseases Initiative, Nairobi, Kenya), Abhilasha Karkey (Oxford University Clinical Research Unit Nepal, Nepal), Gregory L Kearns (Professor of Pediatrics and Medical Education, The Burnett School of Medicine at Texas Christian University, Fort Worth, TX, United States of America), Karen Helena Keddy (Independent Consultant, South Africa), Nina Khanna (University Hospital Basel, Switzerland), Akiko Kitamura (Health, Nutrition and Population Global Practice, World Bank Group, United States of America), Kaija-Leena Kolho (Children's Hospital, University of Helsinki and HUS, Helsinki, Finland), Dimitrios P Kontoyiannis (Division of Internal Medicine, Houston, TX, United States of America), Anita Kotwani (Ex-Director professor, Department of Pharmacology, V. P. Chest Institute, University of Delhi, India), Roman S Kozlov (Smolensk State Medical University, Russia), Katharina Kranzer (London School of Hygiene and Tropical Medicine, United Kingdom), Ranmini Kularatne (Labtests Auckland, New Zealand), Monica M Lahra (WHO Collaborating Centre for ST and AMR, NSWHP Microbiology, The Prince of Wales Hospital, NSW, Australia), Bradley J Langford (Public Health Ontario, Canada), Rafael Laniado-Laborin (Hospital General Tijuana, ISESALUD de Baja California, Mexico), Joakim Larsson (University of Gothenburg, Sweden), Cornelia Lass-Flörl (Institute of Hygiene and Medical Microbiology European Excellence Center of Medical Mycology (ECMM), Medical University of Innsbruck, Innsbruck, Germany), Kirsty Le Doare (St. George's University of London, United Kingdom; Makerere University, Kampala, Uganda), Hyukmin Lee (Severance Hospital, Yonsei University Medical College, Republic of Korea), Fernanda Lessa (Centers for Disease Control and Prevention, United States of America), Anna S Levin (Universidade de São Paulo, Brazil), Direk Limmathurotsakul (Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Bangkok, Thailand; Department of Tropical Hygiene, Faculty of Tropical Medicine, Bangkok, Thailand; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom), Nilton Lincopan (Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, Brazil), Andrea Lo Vecchio (University of Naples Federico II, Italy), Rakesh Lodha (All India Institute of Medical Sciences, India), Mark Loeb (McMaster University, Canada), Yves Longtin (Jewish General Hospital, Montreal, Canada), David Chien Lye (National Centre for Infectious Diseases; Tan Tock Seng Hospital; Yong Loo Lin School of Medicine; Lee Kong Chian School of Medicine, Singapore), Asif Mujtaba Mahmud (Asgar Ali Hospital, Dhaka; Bangladesh Lung Foundation; Formerly at Institute of Epidemiology, Disease Control and Research (IEDCR), Mahakhali, Dhaka, Bangladesh), Célia Manaia (Universidade Católica Portuguesa, Portugal), Lenore Manderson (University of the Witwatersrand, South Africa), Ivana Mareković (University Hospital Centre Zagreb, Department of Clinical Microbiology, Infection Prevention and Control, Zagreb, Croatia), Kalisvar Marimuthu (Tan Tock Seng, Hospital and National Centre for Infectious Diseases, Singapore), Irene Martin (National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada), Tapfumanei Mashe (WHO, Ministry of Health and Child Care, Zimbabwe), Zeng Mei (Children's Hospital of Fudan University, National Children's Medical Center, China), Jacques F Meis (University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen-Bonn- Cologne-Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany), Flávio Augusto Lyra Tavares De Melo (Governo do Estado da Paraíba, Brazil), Marc Mendelson (University of Cape Town, South Africa), Angelica Espinosa Miranda (Ministério da Saúde, Brazil), David Moore (Department of Paediatrics and Child Health, Chris Hani Baragwanath Academic Hospital, University of the Witwatersrand, Johannesburg, South Africa; South African Medical Research Council Vaccine and Infectious Diseases Analytics (VIDA) Research Unit, University of the Witwatersrand, Johannesburg, South Africa), Chantal Morel (University Hospital Bonn, Institute for Hygiene & Public Health, Germany), Nyambura Moremi (National Public Health Laboratory, Tanzania), Maria Luisa Moro (Regional Health and Social Agency, Emilia Romagna Region, Italy), Francis Moussy (World Health Organization, Geneva, Switzerland), Stephen Mshana (Catholic University of Health and Allied Sciences, Tanzania), Arno Mueller (World Health Organization, Geneva, Switzerland), Francis J Ndow (Skin and GU Medicine Clinic, Harare, Zimbabwe), Mark Nicol (University of Western Australia, Australia), Andrew Nunn (MRC Clinical Trials Unit at University College London, United Kingdom), Stephen Obaro (University of Nebraska Medical Center, United States of America), Christina W Obiero (Kenya Medical Research Insistute - Wellcome Trust Research Programme, Kenya), Iruka N Okeke (University of Ibadan, Nigeria), Uduak Okomo (MRC Unit The Gambia at London School of Hygiene and Tropical Medicine, Gambia), Tochi J Okwor (Nigeria Centre for Disease Control and Prevention, Nigeria), Rita Oladele (College of Medicine, University of Lagos, Nigeria), Sylvia Omulo (Washington State University, United States of America), Pascale Ondoa (African Society for Laboratory Medicine (ASLM), Ethiopia), Juana Medarda Ortellado de Canese (Universidad Nacional de Asunción, Paraguay), Luis Ostrosky-Zeichner (University of Texas Health Science Center at Houston, United States of America), Maria Clara Padoveze (School of Nursing, University of São Paulo, Brazil), Madhukar Pai (McGill University, Canada), Benjamin Park (Centers for Disease Control and Prevention, United States of America), Julian Parkhill (University of Cambridge, United Kingdom), Christopher M Parry (Liverpool School of Tropical Medicine, United Kingdom), Rosanna Peeling (London School of Hygiene and Tropical Medicine, United Kingdom), Luísa Maria Sobreira Vieira Peixe (Faculdade de Farmácia, Universidade do Porto, Portugal), Olga Perovic (National Institute for Communicable Diseases a division of NHLS, South Africa), Melinda M Pettigrew (Yale School of Public Health, United States of America), Nicola Principi (University of Milan, Italy), Céline Pulcini (Université de Lorraine et CHRU Nancy, APEMAC et Centre régional en antibiothérapie du Grand Est AntibioEst, Nancy, France), Nelly Puspandari (Health Policy Agency, Ministry of Health Indonesia, Indonesia), Timothy Rawson (Imperial College London, United Kingdom), Denasha Lavanya Reddy (University of the Witwatersrand, South Africa), Kessendri Reddy (University of the Witwatersrand, South Africa), Paulo Redner (Fundação Oswaldo Cruz. Escola Nacional de Saúde Pública Sergio Arouca. Centro de Referência Professor Hélio Fraga. Rio de Janeiro, RJ, Brasil), Juan Luis Rodríguez Tudela (Global Action for Fungal Infections, United Kingdom), Jesús Rodríguez-Baño (Unidad Clínica de Enfermedades Infecciosas y Microbiología, Instituto de Biomedicina de Sevilla (IBiS)/CSIC, Hospital Universitario Virgen Macarena; Departamento de Medicina, Universidad de Sevilla, Seville, Spain. CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain), Susan Rogers Van Katwyk (Global Strategy Lab, Canada), Emmanuel Roilides (Infectious Diseases Unit, 3rd Department Pediatrics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, and Hippokration General Hospital, Thessaloniki, Greece), Christine Rollier (University of Surrey, United Kingdom), Leslie Rollock (Ministry of Health and Wellness, Barbados), Jean-Baptiste Ronat (IQLS, France), Etienne Ruppe (Université de Paris, France), Manish Sadarangani (University of British Columbia, Canada), David Salisbury (Programme for Global Health, Chatham House, London, United Kingdom), Mounerou Salou (Université de Lomé, Togo), Luc Hervé Samison (Centre d'infectiologie Charles Mérieux, University of Antananarivo, Madagascar), Maurizio Sanguinetti (Fondazione Policlinico Universitario A. Gemelli IRCCS, Italy), Massimo Sartelli (Department of Surgery, Macerata Hospital, Italy), Natalie Schellack (University of Pretoria, South Africa), Jeroen Schouten (Radboud University, Netherlands), Mitchell J Schwaber (National Center for Infection Control, Israel Ministry of Health, Israel), Jeremiah Seni (Catholic University of Health and Allied Sciences (CUHAS), Mwanza, Tanzania), Abiola Senok (College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates; School of Dentistry, Cardiff University, Cardiff, United Kingdom), William M Shafer (Emory University School of Medicine, United States of America), Sadia Shakoor (Aga Khan University, Pakistan), Donald Sheppard (Public Health Agency of Canada, Canada), Jong-Hee Shin (Chonnam National University Medical School, Republic of Korea), Sonia Sia (Research Institute for Tropical Medicine, Philippines), Dawn Sievert (Centers for Disease Control and Prevention, United States of America), Ishwar Singh (Antimicrobial Pharmacodynamics and Therapeutics, Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, United Kingdom; Antimicrobial Drug Discovery, Department of Chemistry, The Robert Robinson Laboratories, University of Liverpool, Liverpool, United Kingdom), Rupak Singla (National Institute of Tuberculosis and Respiratory diseases, New Delhi, India), Robert Leo Skov (International Centre for Antimicrobial Resistance Solutions (ICARS)), Olusegun O Soge (University of Washington, Seattle, United States of America), Rosanne Sprute (Faculty of Medicine and University Hospital Cologne, University of Cologne, Germany), Arjun Srinivasan (University of Queensland, Australia), Subasree Srinivasan (Centers for Disease Control and Prevention, United States of America), Arnfinn Sundsfjord (UiT The Arctic University of Norway, Norway), Evelina Tacconelli (University of Verona, Italy), Sabira Tahseen (National Tuberculosis Control Program, Pakistan), Viroj Tangcharoensathien (International Health Policy Program, Ministry of Public Health, Thailand), Thomas Tängdén (Department of Medical Sciences, Uppsala University, Uppsala, Sweden), Karin Thursky (University of Melbourne, Australia), Guy Thwaites (University of Oxford, Vietnam), Renata Tigulini de Souza Peral (Ministry of Health, Brazil), Deborah Tong (World Health Organization, Geneva, Switzerland), Hafsah Deepa Tootla (National Health Laboratory Services, Red Cross War Memorial Children's Hospital, Cape Town, South Africa), Constantinos Tsioutis (European University Cyprus, Nicosia, Cyprus), Katy M Turner (Aquarius Population Health, United Kingdom), Paul Turner (Aquarius Population Health, United Kingdom), Shaheed Vally Omar (National Institute for Communicable Diseases, a division of the National Health Laboratory Service, South Africa), Wendy Wj van de Sande (Erasmus MC, University Medical Center Rotterdam, Department of Medical Microbiology and Infectious Diseases, Netherlands), Susan van den Hof (National Institute for Public Health and the Environment, Netherlands), Rogier van Doorn (Ha Noi Oxford University Clinical Research Unit, University of Oxford, United Kingdom), Balaji Veeraraghavan (Christian Medical College, India), Paul Verweij (Radboudumc - CWZ Center of Expertise for Mycology; Center for Infectious Disease Research, Diagnostics and Laboratory Surveillance, the Netherlands), Retno Wahyuningsih (Department of Parasitology, Universitas Indonesia, Faculty of Medicine, Jakarta, Indonesia; Department of Parasitology, Universitas Kristen Indonesia, Faculty of Medicine, Jakarta, Indonesia), Hui Wang (Peking University People's Hospital, Beijing, China), Adilia Warris (MRC Centre for Medical Mycology, University of Exeter, United Kingdom), Hillard Weinstock (No institutional affiliation, United States of America), Evelyn Wesangula (East Central and Southern Africa Health Community, Arusha, Tanzania), David Whiley (University of Queensland, Australia), Peter J White (Imperial College London, United Kingdom; United Kingdom Health Security Agency, United Kingdom), Phoebe Williams (University of Sydney / Sydney Children's Hospital Network, Australia), Yonghong Xiao (Zhejiang University, China), Martin Yagui Moscoso (Instituto Nacional de Salud, Peru, and Universidad Nacional Mayor de San Marcos, Peru), Hsu Li Yang (National University of Singapore, Singapore), Sachiyo Yoshida ol (World Health Organization, Geneva, Switzerland), Yunsong Yu (Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, China), Dorota Żabicka (National Medicines Institute, Warsaw, Poland), Matteo Zignol (World Health Organization, Geneva, Switzerland).
Author
Affilliation
Abstract
The WHO research agenda for antimicrobial resistance (AMR) in human health has identified 40 research priorities to be addressed by the year 2030. These priorities focus on bacterial and fungal pathogens of crucial importance in addressing AMR, including drug-resistant pathogens causing tuberculosis. These research priorities encompass the entire people-centred journey, covering prevention, diagnosis, and treatment of antimicrobial-resistant infections, in addition to addressing the overarching knowledge gaps in AMR epidemiology, burden and drivers, policies and regulations, and awareness and education. The research priorities were identified through a multistage process, starting with a comprehensive scoping review of knowledge gaps, with expert inputs gathered through a survey and open call. The priority setting involved a rigorous modified Child Health and Nutrition Research Initiative approach, ensuring global representation and applicability of the findings. The ultimate goal of this research agenda is to encourage research and investment in the generation of evidence to better understand AMR dynamics and facilitate policy translation for reducing the burden and consequences of AMR.
Publisher
Elsevier
Citation
BERTAGNOLIO, Silvia et al. WHO global research priorities for antimicrobial resistance in human health. The Lancet Microbe, p. 1-14, 12 Aug. 2024.DOI
10.1016/S2666-5247(24)00134-4ISSN
2666-5247Notes
Produção científica do Laboratório de Inovações em Terapias, Ensino e Bioprodutos.Anna Cristina Calçada Carvalho – Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Inovações em Terapias, Ensino e Bioprodutos. Rio de Janeiro, RJ, Brasil. Documento produzido em parceria ou por autor vinculado à Fiocruz, mas não consta a informação no documento.
Paulo Redner – Fundação Oswaldo Cruz. Escola Nacional de Saúde Pública Sergio Arouca. Centro de Referência Professor Hélio Fraga. Rio de Janeiro, RJ, Brasil. Documento produzido em parceria ou por autor vinculado à Fiocruz, mas não consta a informação no documento.
WHO Research Agenda for AMR in Human Health Collaborators: David Aanensen (University of Oxford, United Kingdom), Alexandre Alanio (Institut Pasteur, Université Paris Cité, National Reference Center for Invasive Mycoses and Antifungals, Translational Mycology research group, Mycology Department, Paris, France; Laboratoire de parasitologie-mycologie, AP-HP, Hôpital Saint-Louis, Paris, France), Ana Alastruey-Izquierdo (Instituto de Salud Carlos III, Spain), Tinsae Alemayehu (St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia and American medical center, Addis Ababa, Ethiopia), Majdi Al-Hasan (University of South Carolina School of Medicine; Prisma Health-Midlands, Columbia, South Carolina, United States of America), Karel Allegaert (KU Leuven, Belgium), Amal Saif Al-Maani (Ministry of Health, Oman), Jameela Al-Salman (Salmaniya Medical Complex, Bahrain), Abeer Nizar Alshukairi (Alfaisal University in Riyadh, Saudi Arabia; Previously King Faisal Specialist Hospital and Research Center in Jeddah, Saudi Arabia), Afreenish Amir (National Institute of Health, Pakistan), Tanya Applegate (Kirby Institute, UNSW Sydney, Australia), George F Araj (American University of Beirut - Medical Center, Lebanon), Marlen Arce Villalobos (Ministerio de Salud, Costa Rica), Christine Årdal (Norwegian Institute of Public Health, Norway), Diane Ashiru-Oredope (UK Health Security Agency, United Kingdom), Elizabeth A Ashley (Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU), Mahosot Hospital, Vientiane, Lao PDR; Centre for Tropical Medicine & Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK), François-Xavier Babin (Fondation Mérieux, France), Laura H Bachmann (Centers for Disease Control and Prevention, United States of America), Till Bachmann (Centre for Inflammation Research, Institute for Regeneration and Repair, The University of Edinburgh, Edinburgh), Kate Susan Baker (Department of Genetics, University of Cambridge, Downing Place, Cambridge, United Kingdom), Manica Balasegaram (Global Antibiotic R&D Partnership (GARDP)), Colleen Bamford (Pathcare, South Africa), Fernando Baquero (Ramón y Cajal Institute for Health Research, Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Spain), Laura Isabel Barcelona (Ministerio de Salud de la Nación, Argentina), Quique Bassat (Barcelona Institute for Global Health (ISGlobal), Spain), Matteo Bassetti (University of Genoa, Italy), Sulagna Basu (ICMR-National Institute of Cholera and Enteric Diseases, Kolkata, India), Justin Beardsley (University of Sydney, Australia), Grey Benoit Vásquez (Dirección de Epidemiología, Ministerio de Salud Pública y Asistencia Social, Dominican Republic), James A Berkley (KEMRI/Wellcome Trust Research Programme, Kilifi, Kenya; Centre for Tropical Medicine & Global Health, University of Oxford, UK), Anuj K Bhatnagar (Rajan Babu Institute for Pulmonary Medicine and Tuberculosis, India), Julia Bielicki (St George's University of London, United Kingdom; University of Basel Children's Hospital, Switzerland), Julie Bines (The University of Melbourne; Murdoch Children's Research Institute; Department of Gastroenterology and Clinical Nutrition, The Royal Children's Hospital), Felix Bongomin (Gulu University, Uganda), Robert A Bonomo (Cleveland VA Medical Center, Case Western Reserve University, United States of America), John S Bradley (University of California, San Diego, School of Medicine), Catriona Bradshaw (Monash University, Australia), Ana Brett (Clínica Universitária de Pediatria, Faculdade de Medicina, Universidade de Coimbra, Portugal), Adrian Brink (University of Cape Town, South Africa), Colin Brown (UK Health Security Agency, United Kingdom), Jeremy Brown (University College London, United Kingdom), Kirsty Buising (Victorian Infectious Diseases Unit, Royal Melbourne Hospital, Australia; Department of Infectious Diseases, University of Melbourne, Australia), Carolee Carson (Public Health Agency of Canada, Canada), Anna Cristina Calçada Carvalho (Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Inovações em Terapias, Ensino e Bioprodutos. Rio de Janeiro, RJ, Brasil), Elio Castagnola (IRCCS Istituto Giannina Gaslini, Italy), Marco Cavaleri (European Medicines Agency, Netherlands), Michele Cecchini (Organisation for Economic Co-operation and Development (OECD), France), Chishala Chabala (University of Zambia, Zambia), Richard E Chaisson (Johns Hopkins University School of Medicine; Johns Hopkins Center for Tuberculosis Research; Johns Hopkins Center for AIDS Research), Arunaloke Chakrabarti (Doodhadhari Burfani Hospital and Research Institute, Haridwar, India), Clare Chandler (London School of Hygiene and Tropical Medicine, United Kingdom), Sujith John Chandy (Department of Pharmacology & Clinical Pharmacology, Christian Medical College, Vellore, India), Esmita Charani (Imperial College London, United Kingdom), Lisa Chen (UCSF Curry International Tuberculosis Center, United States of America), Francesca Chiara (Center for Infectious Disease Research and Policy, United States of America), Anuradha Chowdhary (Medical Mycology Unit, Department of Microbiology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi; National Reference Laboratory For Antimicrobial Resistance in Fungal Pathogens, Medical Mycology Unit, Department of Microbiology, Patel Chest Institute, University of Delhi, Delhi, India), Arlene Chua (Médecins Sans Frontières, Switzerland), Pem Chuki (Jigme Dorji Wangchuck National Referral Hospital, Bhutan), Doo Ryeon Chun (Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea), Gavin Churchyard (The Aurum Institute, Parktown, South Africa; Department of Medicine, Vanderbilt University, Nashville, TN, US), Daniela Cirillo (San Raffaele Scientific Institute, Italy), Lauren Clack (University of Zurich, Institute for Implementation Science in Health Care, Zurich, Switzerland), Susan E Coffin (Children's Hospital of Philadelphia /University of Pennsylvania School of Medicine, United States of America), Jennifer Cohn (Global Antibiotic R&D Partnership (GARDP)), Michelle Cole (STI Reference Laboratory, UKHSA, London, UK), John Conly (University of Calgary and Alberta Health Services, Canada), Ben Cooper (University of Oxford, United Kingdom), Alejandra Corso (Servicio Antimicrobianos - INEI ANLIS Dr Carlos G. Malbrán, Argentina), Sara E Cosgrove (Johns Hopkins University School of Medicine, United States of America), Helen Cox (Institute of Infectious Diseases and Molecular Medicine, Division of Medical Microbiology, University of Cape Town), Charles L Daley (National Jewish Center, United States of America), Saffiatou Darboe (MRC Unit The Gambia at the LSHTM), Tom Darton (University of Sheffield, United Kingdom), Gerry Davies (University of Liverpool, United Kingdom), Viviana de Egea (Ministry of Health, Paraguay), Amela Dedeić-Ljubović (Clinical Center of the University Sarajevo, Bosnia and Herzegovina), Miranda Deeves (World Health Organization, Geneva, Switzerland), Claudia Denkinger (Division of Infectious Disease and Tropical Medicine, German Center for Infection Research (DZIF) partner site, University Hospital Heidelberg, Germany), Jo-Anne R Dillon (University of Saskatchewan, Canada), Angela Dramowski (Stellenbosch University, South Africa), Brian Eley (Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa), Susanna Maria Roberta Esposito (University of Parma, Italy), Sabiha Y Essack (Antimicrobial Research Unit, School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa), Helmia Farida (Universitas Diponegoro, Indonesia), Joveria Farooqi (Aga Khan University, Karachi, Pakistan), Nicholas Feasey (School of Medicine, University of St Andrews, St Andrews, UK and Liverpool School of Tropical Medicine, Liverpool, UK), Cecilia Ferreyra (FIND, Switzerland), Helen Fifer (UK Health Security Agency, United Kingdom), Heather Finlayson (FIND, Switzerland), Mike Frick (Treatment Action Group, United States of America), Ana Cristina Gales (Universidade Federal de São Paulo, Brazil), Luisa Galli (Department of Health Science, University of Florence and Infectious Disease Unit, Meyer Children's Hospital, IRCCS, Florence, Italy), Sumanth Gandra (Washington University School of Medicine in St. Louis, United States of America), Jeffrey S Gerber (Children's Hospital of Philadelphia, United States of America), Christian Giske (Karolinska Institute, Sweden), Bruce Gordon (World Health Organization, Geneva, Switzerland), Nelesh Govender (National Institute for Communicable Diseases, South Africa), Nathalie Guessennd (Institut Pasteur de Côte d'Ivoire, Ivory Coast), Ibrehima Guindo (National Institute of Public Health, Bamako-Mali, Mali), Elmira Gurbanova (Tartu University Clinic, Estonia), Amanda Gwee (Department of General Medicine, Royal Children's Hospital, Antimicrobials Group, Murdoch Children's Research Institute, Department of Paediatrics, The University of Melbourne), Ferry Hagen (Westerdijk Fungal Biodiversity Institute (WI-KNAW), Netherlands), Stephan Harbarth (University Hospital Geneva (HUG), Switzerland), John Haze (Ministry of Health, St Vincent & the Grenadines), Jutta Heim (Helmholtz Centre for Infection Research, Switzerland), Rene Hendriksen (Technical University of Denmark, Denmark), Robert Simon Heyderman (University College London (UCL), United Kingdom), Kathryn Elizabeth Holt (London School of Hygiene and Tropical Medicine, United Kingdom), Martin Hönigl (Medical University of Graz, Austria), Edward W Hook (University of Alabama at Birmingham, United States of America), William Hope (University of Liverpool, United Kingdom), Heidi Hopkins (London School of Hygiene and Tropical Medicine, United Kingdom), Gwenda Hughes (London School of Hygiene and Tropical Medicine, United Kingdom), Ghada Ismail (Supreme Council for University Hospitals, Egypt), Mohammad Iqbal Issack (Central Health Laboratory, Ministry of Health and Wellness, Mauritius), Jan Jacobs (Institute of Tropical Medicine, Antwerp, Belgium), Dušan Jasovský (Médecins Sans Frontières Access Campaign, Switzerland), Fyeza Jehan (The Aga Khan University, Pakistan), Antonieta Jimenez Pearson (National Reference Center of Bacteriology - INCIENSA, Costa Rica), Makoto Jones (University of Utah, United States of America), Mohan P Joshi (Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program, Management Sciences for Health, United States of America), Arti Kapil (North DMC Medical College and Hindu Rao Hospital, India), Samuel Kariuki (Director Eastern Africa, Drugs for Neglected Diseases Initiative, Nairobi, Kenya), Abhilasha Karkey (Oxford University Clinical Research Unit Nepal, Nepal), Gregory L Kearns (Professor of Pediatrics and Medical Education, The Burnett School of Medicine at Texas Christian University, Fort Worth, TX, United States of America), Karen Helena Keddy (Independent Consultant, South Africa), Nina Khanna (University Hospital Basel, Switzerland), Akiko Kitamura (Health, Nutrition and Population Global Practice, World Bank Group, United States of America), Kaija-Leena Kolho (Children's Hospital, University of Helsinki and HUS, Helsinki, Finland), Dimitrios P Kontoyiannis (Division of Internal Medicine, Houston, TX, United States of America), Anita Kotwani (Ex-Director professor, Department of Pharmacology, V. P. Chest Institute, University of Delhi, India), Roman S Kozlov (Smolensk State Medical University, Russia), Katharina Kranzer (London School of Hygiene and Tropical Medicine, United Kingdom), Ranmini Kularatne (Labtests Auckland, New Zealand), Monica M Lahra (WHO Collaborating Centre for ST and AMR, NSWHP Microbiology, The Prince of Wales Hospital, NSW, Australia), Bradley J Langford (Public Health Ontario, Canada), Rafael Laniado-Laborin (Hospital General Tijuana, ISESALUD de Baja California, Mexico), Joakim Larsson (University of Gothenburg, Sweden), Cornelia Lass-Flörl (Institute of Hygiene and Medical Microbiology European Excellence Center of Medical Mycology (ECMM), Medical University of Innsbruck, Innsbruck, Germany), Kirsty Le Doare (St. George's University of London, United Kingdom; Makerere University, Kampala, Uganda), Hyukmin Lee (Severance Hospital, Yonsei University Medical College, Republic of Korea), Fernanda Lessa (Centers for Disease Control and Prevention, United States of America), Anna S Levin (Universidade de São Paulo, Brazil), Direk Limmathurotsakul (Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Bangkok, Thailand; Department of Tropical Hygiene, Faculty of Tropical Medicine, Bangkok, Thailand; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom), Nilton Lincopan (Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, Brazil), Andrea Lo Vecchio (University of Naples Federico II, Italy), Rakesh Lodha (All India Institute of Medical Sciences, India), Mark Loeb (McMaster University, Canada), Yves Longtin (Jewish General Hospital, Montreal, Canada), David Chien Lye (National Centre for Infectious Diseases; Tan Tock Seng Hospital; Yong Loo Lin School of Medicine; Lee Kong Chian School of Medicine, Singapore), Asif Mujtaba Mahmud (Asgar Ali Hospital, Dhaka; Bangladesh Lung Foundation; Formerly at Institute of Epidemiology, Disease Control and Research (IEDCR), Mahakhali, Dhaka, Bangladesh), Célia Manaia (Universidade Católica Portuguesa, Portugal), Lenore Manderson (University of the Witwatersrand, South Africa), Ivana Mareković (University Hospital Centre Zagreb, Department of Clinical Microbiology, Infection Prevention and Control, Zagreb, Croatia), Kalisvar Marimuthu (Tan Tock Seng, Hospital and National Centre for Infectious Diseases, Singapore), Irene Martin (National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada), Tapfumanei Mashe (WHO, Ministry of Health and Child Care, Zimbabwe), Zeng Mei (Children's Hospital of Fudan University, National Children's Medical Center, China), Jacques F Meis (University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen-Bonn- Cologne-Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany), Flávio Augusto Lyra Tavares De Melo (Governo do Estado da Paraíba, Brazil), Marc Mendelson (University of Cape Town, South Africa), Angelica Espinosa Miranda (Ministério da Saúde, Brazil), David Moore (Department of Paediatrics and Child Health, Chris Hani Baragwanath Academic Hospital, University of the Witwatersrand, Johannesburg, South Africa; South African Medical Research Council Vaccine and Infectious Diseases Analytics (VIDA) Research Unit, University of the Witwatersrand, Johannesburg, South Africa), Chantal Morel (University Hospital Bonn, Institute for Hygiene & Public Health, Germany), Nyambura Moremi (National Public Health Laboratory, Tanzania), Maria Luisa Moro (Regional Health and Social Agency, Emilia Romagna Region, Italy), Francis Moussy (World Health Organization, Geneva, Switzerland), Stephen Mshana (Catholic University of Health and Allied Sciences, Tanzania), Arno Mueller (World Health Organization, Geneva, Switzerland), Francis J Ndow (Skin and GU Medicine Clinic, Harare, Zimbabwe), Mark Nicol (University of Western Australia, Australia), Andrew Nunn (MRC Clinical Trials Unit at University College London, United Kingdom), Stephen Obaro (University of Nebraska Medical Center, United States of America), Christina W Obiero (Kenya Medical Research Insistute - Wellcome Trust Research Programme, Kenya), Iruka N Okeke (University of Ibadan, Nigeria), Uduak Okomo (MRC Unit The Gambia at London School of Hygiene and Tropical Medicine, Gambia), Tochi J Okwor (Nigeria Centre for Disease Control and Prevention, Nigeria), Rita Oladele (College of Medicine, University of Lagos, Nigeria), Sylvia Omulo (Washington State University, United States of America), Pascale Ondoa (African Society for Laboratory Medicine (ASLM), Ethiopia), Juana Medarda Ortellado de Canese (Universidad Nacional de Asunción, Paraguay), Luis Ostrosky-Zeichner (University of Texas Health Science Center at Houston, United States of America), Maria Clara Padoveze (School of Nursing, University of São Paulo, Brazil), Madhukar Pai (McGill University, Canada), Benjamin Park (Centers for Disease Control and Prevention, United States of America), Julian Parkhill (University of Cambridge, United Kingdom), Christopher M Parry (Liverpool School of Tropical Medicine, United Kingdom), Rosanna Peeling (London School of Hygiene and Tropical Medicine, United Kingdom), Luísa Maria Sobreira Vieira Peixe (Faculdade de Farmácia, Universidade do Porto, Portugal), Olga Perovic (National Institute for Communicable Diseases a division of NHLS, South Africa), Melinda M Pettigrew (Yale School of Public Health, United States of America), Nicola Principi (University of Milan, Italy), Céline Pulcini (Université de Lorraine et CHRU Nancy, APEMAC et Centre régional en antibiothérapie du Grand Est AntibioEst, Nancy, France), Nelly Puspandari (Health Policy Agency, Ministry of Health Indonesia, Indonesia), Timothy Rawson (Imperial College London, United Kingdom), Denasha Lavanya Reddy (University of the Witwatersrand, South Africa), Kessendri Reddy (University of the Witwatersrand, South Africa), Paulo Redner (Fundação Oswaldo Cruz. Escola Nacional de Saúde Pública Sergio Arouca. Centro de Referência Professor Hélio Fraga. Rio de Janeiro, RJ, Brasil), Juan Luis Rodríguez Tudela (Global Action for Fungal Infections, United Kingdom), Jesús Rodríguez-Baño (Unidad Clínica de Enfermedades Infecciosas y Microbiología, Instituto de Biomedicina de Sevilla (IBiS)/CSIC, Hospital Universitario Virgen Macarena; Departamento de Medicina, Universidad de Sevilla, Seville, Spain. CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain), Susan Rogers Van Katwyk (Global Strategy Lab, Canada), Emmanuel Roilides (Infectious Diseases Unit, 3rd Department Pediatrics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, and Hippokration General Hospital, Thessaloniki, Greece), Christine Rollier (University of Surrey, United Kingdom), Leslie Rollock (Ministry of Health and Wellness, Barbados), Jean-Baptiste Ronat (IQLS, France), Etienne Ruppe (Université de Paris, France), Manish Sadarangani (University of British Columbia, Canada), David Salisbury (Programme for Global Health, Chatham House, London, United Kingdom), Mounerou Salou (Université de Lomé, Togo), Luc Hervé Samison (Centre d'infectiologie Charles Mérieux, University of Antananarivo, Madagascar), Maurizio Sanguinetti (Fondazione Policlinico Universitario A. Gemelli IRCCS, Italy), Massimo Sartelli (Department of Surgery, Macerata Hospital, Italy), Natalie Schellack (University of Pretoria, South Africa), Jeroen Schouten (Radboud University, Netherlands), Mitchell J Schwaber (National Center for Infection Control, Israel Ministry of Health, Israel), Jeremiah Seni (Catholic University of Health and Allied Sciences (CUHAS), Mwanza, Tanzania), Abiola Senok (College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates; School of Dentistry, Cardiff University, Cardiff, United Kingdom), William M Shafer (Emory University School of Medicine, United States of America), Sadia Shakoor (Aga Khan University, Pakistan), Donald Sheppard (Public Health Agency of Canada, Canada), Jong-Hee Shin (Chonnam National University Medical School, Republic of Korea), Sonia Sia (Research Institute for Tropical Medicine, Philippines), Dawn Sievert (Centers for Disease Control and Prevention, United States of America), Ishwar Singh (Antimicrobial Pharmacodynamics and Therapeutics, Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, United Kingdom; Antimicrobial Drug Discovery, Department of Chemistry, The Robert Robinson Laboratories, University of Liverpool, Liverpool, United Kingdom), Rupak Singla (National Institute of Tuberculosis and Respiratory diseases, New Delhi, India), Robert Leo Skov (International Centre for Antimicrobial Resistance Solutions (ICARS)), Olusegun O Soge (University of Washington, Seattle, United States of America), Rosanne Sprute (Faculty of Medicine and University Hospital Cologne, University of Cologne, Germany), Arjun Srinivasan (University of Queensland, Australia), Subasree Srinivasan (Centers for Disease Control and Prevention, United States of America), Arnfinn Sundsfjord (UiT The Arctic University of Norway, Norway), Evelina Tacconelli (University of Verona, Italy), Sabira Tahseen (National Tuberculosis Control Program, Pakistan), Viroj Tangcharoensathien (International Health Policy Program, Ministry of Public Health, Thailand), Thomas Tängdén (Department of Medical Sciences, Uppsala University, Uppsala, Sweden), Karin Thursky (University of Melbourne, Australia), Guy Thwaites (University of Oxford, Vietnam), Renata Tigulini de Souza Peral (Ministry of Health, Brazil), Deborah Tong (World Health Organization, Geneva, Switzerland), Hafsah Deepa Tootla (National Health Laboratory Services, Red Cross War Memorial Children's Hospital, Cape Town, South Africa), Constantinos Tsioutis (European University Cyprus, Nicosia, Cyprus), Katy M Turner (Aquarius Population Health, United Kingdom), Paul Turner (Aquarius Population Health, United Kingdom), Shaheed Vally Omar (National Institute for Communicable Diseases, a division of the National Health Laboratory Service, South Africa), Wendy Wj van de Sande (Erasmus MC, University Medical Center Rotterdam, Department of Medical Microbiology and Infectious Diseases, Netherlands), Susan van den Hof (National Institute for Public Health and the Environment, Netherlands), Rogier van Doorn (Ha Noi Oxford University Clinical Research Unit, University of Oxford, United Kingdom), Balaji Veeraraghavan (Christian Medical College, India), Paul Verweij (Radboudumc - CWZ Center of Expertise for Mycology; Center for Infectious Disease Research, Diagnostics and Laboratory Surveillance, the Netherlands), Retno Wahyuningsih (Department of Parasitology, Universitas Indonesia, Faculty of Medicine, Jakarta, Indonesia; Department of Parasitology, Universitas Kristen Indonesia, Faculty of Medicine, Jakarta, Indonesia), Hui Wang (Peking University People's Hospital, Beijing, China), Adilia Warris (MRC Centre for Medical Mycology, University of Exeter, United Kingdom), Hillard Weinstock (No institutional affiliation, United States of America), Evelyn Wesangula (East Central and Southern Africa Health Community, Arusha, Tanzania), David Whiley (University of Queensland, Australia), Peter J White (Imperial College London, United Kingdom; United Kingdom Health Security Agency, United Kingdom), Phoebe Williams (University of Sydney / Sydney Children's Hospital Network, Australia), Yonghong Xiao (Zhejiang University, China), Martin Yagui Moscoso (Instituto Nacional de Salud, Peru, and Universidad Nacional Mayor de San Marcos, Peru), Hsu Li Yang (National University of Singapore, Singapore), Sachiyo Yoshida ol (World Health Organization, Geneva, Switzerland), Yunsong Yu (Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, China), Dorota Żabicka (National Medicines Institute, Warsaw, Poland), Matteo Zignol (World Health Organization, Geneva, Switzerland).
Share